GDC-0339
≥99%
- Product Code: 100604
CAS:
1428569-85-0
| Molecular Weight: | 465.5 g./mol | Molecular Formula: | C₂₀H₂₂F₃N₇OS |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
GDC-0339 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a potent and selective inhibitor of certain kinases that play a critical role in cancer cell proliferation and survival. By targeting these specific kinases, GDC-0339 aims to disrupt signaling pathways that are often dysregulated in various types of cancers, thereby inhibiting tumor growth and progression. Preclinical studies have shown promising results in reducing tumor size and improving survival rates in animal models. Its application is being explored in combination with other anticancer therapies to enhance efficacy and overcome drug resistance. Ongoing research focuses on its potential use in treating solid tumors and hematologic malignancies, with clinical trials underway to evaluate its safety and effectiveness in human patients.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | ฿35,910.00 |
+
-
|
| 0.005 | 10-20 days | ฿66,690.00 |
+
-
|
GDC-0339
GDC-0339 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a potent and selective inhibitor of certain kinases that play a critical role in cancer cell proliferation and survival. By targeting these specific kinases, GDC-0339 aims to disrupt signaling pathways that are often dysregulated in various types of cancers, thereby inhibiting tumor growth and progression. Preclinical studies have shown promising results in reducing tumor size and improving survival rates in animal models. Its application is being explored in combination with other anticancer therapies to enhance efficacy and overcome drug resistance. Ongoing research focuses on its potential use in treating solid tumors and hematologic malignancies, with clinical trials underway to evaluate its safety and effectiveness in human patients.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :